Crossmark

Toxicity profile of camrelizumab-based immunotherapy in older adults with advanced cancer

Published Online: 2024-08-16

Authors

Zhou, Hong

Cai, Li-Li

Lin, Yan-Fang

Ma, Jun-Jie
License Information

Text and Data Mining valid from 2024-08-16

Version of Record valid from 2024-08-16
More Information

Article History

Received: 8 February 2024

Accepted: 12 August 2024

First Online: 16 August 2024

Competing interests

: The authors declare no competing interests.

Document is current